Philippe Quittet

Discipline

Economies et finances (4)

Type de document

Articles (3) Colloques et conférences (2)

Co-auteur

Date

Source

Mot-clé

Filgrastim (5) Lymphomas (5) Finance (5) Finance (5) analyse (4) Chemotherapy (4) Patients (4) Chemotherapy (4) Stem cells--Transplantation (4) Analysis (4) Patients (4) santé publique (3) soins de santé (3) santé (3) politique gouvernementale (3) éducation (3) règlement (3) Education (3) Government policy (3) Public health (3) Medical care (3) Markets (3) Health (3) Government policy (3) Education (3) Regulation (3) Health (3) procès (2) test (1) température (1)

Documents écrit par Philippe Quittet (5) | parle de Philippe Quittet (0)

Cost Effectiveness of Pegfilgrastim Versus Filgrastim After High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with Lymphoma and Myeloma
Lionel Perrier et al. (23 févr. 2013)
Cost-effectiveness of Pegfilgrastim versus Filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma
Lionel Perrier et al. (2013)
A randomised phase II study of the efficacy, safety and cost-effectiveness of pegfilgrastim and filgrastim after autologous stem cell transplant for lymphoma and myeloma (PALM study)
Catherine Sebban et al. (2012)
Pegfilgrastim versus Filgrastim after high-dose chemotherapy and autologous stem cell transplantation in adult patients with lymphoma and myeloma: cost-effectiveness evaluation alongside a randomized controlled trial
Lionel Perrier et al. (10 juil. 2011)
Cost-effectiveness of Pegfilgrastim versus Filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma
Lionel Perrier et al. (25 mai 2011)